Medical Services & Devices
Pfizer secures expanded EU approval for a once-weekly haemophilia treatment, widening care options for patients aged 12 and older across Europe
Pfizer secures expanded EU approval for a once-weekly haemophilia treatment, widening care options for patients aged 12 and older across Europe
Articles
Pharmaceutical giant restarts investment in Cambridge and Macclesfield facilities following government deal, securing thousands of jobs across both sites
Eli Lilly is investing an additional US$4.5bn to expand its Lebanon, Indiana sites for GLP-1 drugs and genetic medicines amid surging demand growth
Top stories include Ecolab's AI Water intelligence, KPMG's CEO report, Colgate-Palmoliveās targets, Novartis' antimalarial drug & Merck Groupās bio-solvent
Eli Lilly is investing an additional US$4.5bn to expand its Lebanon, Indiana sites for GLP-1 drugs and genetic medicines amid surging demand growth
Pharmaceutical giant restarts investment in Cambridge and Macclesfield facilities following government deal, securing thousands of jobs across both sites
PwCās 2026 report reveals womenās health as a US$600bn growth market, underfunded yet expanding beyond reproductive care into a major clinical opportunity
WHO has prequalified Novartis and MMVās Coartem Baby, the first antimalarial for infants two to five kg, addressing a critical gap in African malaria care
Lists
Healthcare Digital takes a look at the top 10 diagnostic companies in the world, ranked by their market capitalisation, including Roche, Danaher and BD
Leading pharmaceutical consulting firms are helping life sciences organisations navigate AI adoption, regulatory complexity and commercial strategy in 2026
Videos
Early in the COVID-19 pandemic Moderna teamed up with Apply Digital to lead its digital transformation and educate the world about Modernaās mRNA platform